文献速递胃肠外科

胃肠道间质瘤微创手术的趋势与结局

Trends and outcomes of minimally invasive surgery for gastrointestinal stromal tumors (GIST).
PubMed 文献 · Surg Endosc · 2022-01-19

基于美国国家癌症数据库(2010-2016)分析8923例胃和3683例小肠间质瘤切除,微创手术使用率显著上升,胃切除以腹腔镜为主。微创与开放手术总生存相当,即使在新辅助治疗或肿瘤≥10 cm患者中亦然;胃切除微创与再入院和90天死亡率更低相关。

要点

  • 微创胃切除与更少再入院和更低90天死亡率相关,小肠切除两者相似。
  • 微创手术未影响生存,即使新辅助治疗或肿瘤≥10 cm患者。

核心结论

  • 微创手术越来越多用于胃和小肠间质瘤切除,术后结局改善,总生存与开放手术相当。

研究设计与样本

  • 回顾性分析美国国家癌症数据库(2010-2016)中胃间质瘤8923例和小肠间质瘤3683例切除病例。

主要发现

  • 胃切除微创比例从2010年机器人2.4%、腹腔镜26.1%、开放71.5%变为2016年机器人9.6%、腹腔镜48.8%、开放41.6%(p<0.001)。
  • 小肠切除微创比例从2010年机器人1%、腹腔镜17.3%、开放81.6%变为2016年机器人3.9%、腹腔镜27.2%、开放68.9%(p<0.001)。
  • 微创胃切除与更少再入院和更低90天死亡率相关,微创小肠切除两者相似。
  • 微创手术未影响生存,即使接受新辅助治疗或肿瘤≥10 cm患者。

临床怎么用

  • 胃和小肠间质瘤切除可考虑微创入路,其围术期结局和生存与开放手术相当。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Minimally invasive surgery (MIS) is increasingly being utilized for the resection of gastrointestinal cancers. National trends for perioperative and oncologic outcomes of MIS for gastrointestinal stromal tumors (GIST) are unknown. We hypothesized that with increased use of MIS, the perioperative outcomes and survival for GIST are preserved. METHODS: The National Cancer Database (2010-2016) was utilized to assess perioperative and oncologic outcomes for GIST of the stomach and small bowel. Kaplan-Meier method and log rank test were used to compare survival outcomes. RESULTS: Data from 8923 gastric and 3683 small bowel resections were analyzed. Over the study period, MIS became the prevalent modality for gastrectomies (2010: robotic: 2.4%, laparoscopic: 26.1%, open: 71.5% vs. 2016: robotic: 9.6%, laparoscopic: 48.8%, open: 41.6%; p < 0.001), with a smaller increase in enterectomies (2010: robotic: 1%, laparoscopic: 17.3%, open: 81.6% vs. 2016: robotic: 3.9%, laparoscopic: 27.2%, open: 68.9%; p < 0.001). Age and Charlson comorbidity index were similar among groups. MIS approaches were associated with fewer readmissions and lower 90 day mortality for gastrectomies and similar rates for enterectomies. MIS did not compromise patient survival even in patients who underwent neoadjuvant treatment or harbored tumors ≥ 10 cm. CONCLUSION: Minimally invasive surgery is increasingly being utilized for resection of gastric and small bowel GIST, with improved postoperative outcomes. In this retrospective review, overall survival after minimally invasive or open surgery was comparable, even in challenging scenarios of neoadjuvant treatment or large tumors (≥ 10 cm).

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Gevorkian J, Le E, Alvarado L, et al. Trends and outcomes of minimally invasive surgery for gastrointestinal stromal tumors (GIST). Surg Endosc. 2022. PMID: 35048188. doi:10.1007/s00464-022-09014-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。